ADAM17 and chronic kidney disease: Calcitriol/VDR suppression of renin, ADAM17 and, also of TNFα gene expression, explain the synergy between the calcitriol analog paricalcitol and the angiotensin II converting enzyme inhibitor enalapril at reducing inflammatory macrophage infiltration in the renal parenchyma in rat CKD (94).